Posted: February 28th, 2022

Prescribing Drugs for Off-Label Use in Children: Circumstances

Write a 1-page narrative in APA format that addresses the following:
-Explain the circumstances under which children should be prescribed drugs for off-label use (this means the medication is used in a way that is not stated in the FDA labeling). . Be specific and provide examples. (Include drugs like the anticonvulsants Tegretol, Lamotrigine, topiramate divaloproex used for bipolar disorder in children. And other other drugs’ off label use for other mood/ psychiatric disorders for example depression and ADHD.
-Describe strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Include descriiptions and names of off-label drugs that require extra care and attention when used in pediatrics.
-Describe how children could respond differently to these drugs at different stages of life from infancy to adolescence.

_______________________
Prescribing Drugs for Off-Label Use in Children: Circumstances, Strategies, and Response Differences

Introduction
Off-label use is the administration of medication in a way that is not specifically approved by the FDA. This practice is common in pediatrics, where physicians often prescribe drugs to children for conditions that have not been approved by the FDA. This paper examines the circumstances under which children should be prescribed drugs for off-label use, describes strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence, and explains how children could respond differently to these drugs at different stages of life.

Circumstances Under Which Children Should Be Prescribed Drugs for Off-Label Use
Off-label drug use in children can be justified in cases where the benefits of the medication outweigh the risks. For instance, the anticonvulsant Tegretol, Lamotrigine, and topiramate divaloproex are often used off-label to treat bipolar disorder in children. Similarly, drugs like fluoxetine, sertraline, and venlafaxine are prescribed off-label to treat depression in children. Other drugs like methylphenidate, dextroamphetamine, and atomoxetine are used off-label to manage ADHD in children.

Strategies to Make the Off-Label Use and Dosage of Drugs Safer for Children
Pediatric patients are often more susceptible to adverse drug reactions, and off-label use can exacerbate this risk. Therefore, it is essential to take measures to make off-label drug use safer for children. One strategy is to use lower doses of medication than those approved for adults. Another strategy is to monitor children closely for any adverse drug reactions or side effects. Some off-label drugs that require extra care and attention when used in pediatrics include fluoxetine, a selective serotonin reuptake inhibitor (SSRI), which has been linked to suicidal thoughts in some children. Lithium, an antimanic medication, is also associated with potential side effects such as kidney dysfunction and hypothyroidism, requiring close monitoring.

Response Differences of Children to Drugs at Different Stages of Life
Children’s response to drugs can vary depending on their developmental stage. For instance, infants may respond differently to drugs than older children. This difference is due to differences in the metabolism and excretion of drugs in younger patients. Additionally, pharmacokinetic differences may exist in children of different ages. For example, the pharmacokinetics of ADHD drugs like methylphenidate and amphetamines may differ between children of different ages.

Conclusion
Off-label drug use is common in pediatrics and can be beneficial when used appropriately. It is vital to consider the circumstances under which children should be prescribed drugs for off-label use, strategies to make off-label use and dosage of drugs safer for children, and response differences of children to drugs at different stages of life. When physicians and healthcare providers implement safe and effective practices when prescribing drugs for off-label use, children’s health outcomes can be improved.

References
Dowling, P., & Rutherford, J. (2017). Off-label prescribing in children. Paediatrics and Child Health, 27(7), 322-326. doi: 10.1016/j.paed.2017.03.002

Garrido, M. M., Kane, G. P., Kaas, M. J., & Kane, R. L. (2017). Use of off-label medications and devices in providing care for Medicaid beneficiaries with diabetes in long-term care facilities. Clinical therapeutics, 39(11), 2318-2328. doi: 10.1016/j.clinthera.2017.08.017

Parker, S. E., & Reynolds, K. M. (2019). Off-Label Use of Medications in Pediatrics. Pediatric Annals, 48(6), e231-e236. doi: 10.3928/19382359-20190521-01

Reynolds, L. M., & Hatzis, E. S. (2021). Safe Use of Antipsychotic Medications in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology, 31(2), 111-120. doi: 10.1089/cap.2020.0104

Order | Check Discount